Effortless Ultrasound. Bulletproof Data.
Our high-throughput and low cost preclinical research solutions will enable your lab to rapidly evaluate disease phenotypes, speeding up time to publication.
SonoVol is a spinout company from
The University of North Carolina at Chapel Hill.
At First Flight Venture Center in Research Triangle Park, North Carolina, we are currently developing an ultrasound imaging platform for preclinical cancer and cardiac disease and drug research.
We are currently accepting applications for our Early Adopter Program.
SonoVol is grateful for the research and development funds awarded by the following agencies and organizations.